Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke among the Elderly
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Upper respiratory tract illnesses have been associated with an increased risk of ischemic heart disease and stroke. During two influenza seasons, we assessed the influence of vaccination against influenza on the risk of hospitalization for heart disease and stroke, hospitalization for pneumonia and influenza, and death from all causes. METHODS: Cohorts of community-dwelling members of three large managed-care organizations who were at least 65 years old were studied during the 1998-1999 and 1999-2000 influenza seasons. Administrative and clinical data were used to evaluate outcomes, with multivariable logistic regression to control for base-line demographic and health characteristics of the subjects. RESULTS: There were 140,055 subjects in the 1998-1999 cohort and 146,328 in the 1999-2000 cohort, of which 55.5 percent and 59.7 percent, respectively, were immunized. At base line, vaccinated subjects were on average sicker, having higher rates of most coexisting conditions, outpatient care, and prior hospitalization for pneumonia than unvaccinated subjects. Unvaccinated subjects, however, were more likely to have been given a prior diagnosis of dementia or stroke. Vaccination against influenza was associated with a reduction in the risk of hospitalization for cardiac disease (reduction of 19 percent during both seasons [P<0.001]), cerebrovascular disease (reduction of 16 percent during the 1998-1999 season [P<0.018] and 23 percent during the 1999-2000 season [P<0.001]), and pneumonia or influenza (reduction of 32 percent during the 1998-1999 season [P<0.001] and 29 percent during the 1999-2000 season [P<0.001]) and a reduction in the risk of death from all causes (reduction of 48 percent during the 1998-1999 season [P<0.001] and 50 percent during the 1999-2000 season [P<0.001]). In analyses according to age, the presence or absence of major medical conditions at base line, and study site, the findings were consistent across all subgroups. CONCLUSIONS: In the elderly, vaccination against influenza is associated with reductions in the risk of hospitalization for heart disease, cerebrovascular disease, and pneumonia or influenza as well as the risk of death from all causes during influenza seasons. These findings highlight the benefits of vaccination and support efforts to increase the rates of vaccination among the elderly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Influenza vaccination as a population-wide prevention measure was associated with a very cost-effective reduction in clinical events.171”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [171]
Citations
Cites
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
Schrag, S. D., Gorwitz, R. J., Fultz-Butts, K., & Schuchat, A. (2002) · PubMed · Cited by 3,349
The number needed to treat: a clinically useful measure of treatment effect
Cook, R. J., & Sackett, D. L. (1995) · BMJ · doi:10.1136/bmj.310.6977.452 · Cited by 1,885
Holtzman, D. J., Powell‐Griner, E., Bolen, J. C., & Rhodes, L. (2000) · PubMed · Cited by 1,110
Nichol, K. L., Margolis, K. L., Wuorenma, J., & Von Sternberg, T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311206 · Cited by 996
Self-citationInfection and Atherosclerosis: Emerging Mechanistic Paradigms
Epstein, S. E., Zhou, Y. F., & Zhu, J. (1999) · Circulation · doi:10.1161/01.cir.100.4.e20 · Cited by 511
Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.
Nichol, K. L., Wuorenma, J., & von Sternberg, T. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.16.1769 · Cited by 484
Self-citationValidation of self-report of influenza and pneumococcal vaccination status in elderly outpatients
Mac Donald, R., Baken, L., Nelson, A., & Nichol, K. L. (1999) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(98)00159-7 · Cited by 410
Self-citationAcute respiratory-tract infections and risk of first-time acute myocardial infarction
Meier, C. R., Jick, S. S., Derby, L. E., Vasilakis, C., Jick, H., Meier, C., Jick, S., Derby, L., Vasilakis, C., & Jick, H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11084-4 · Cited by 389
Vu, T., Farish, S., Jenkins, M., & Kelly, H. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00041-5 · Cited by 376
Research works printed but not linked: 7
- 2002, MMWR Morb Mortal Wkly Rep, 51, 1
- Nichol KL. Efficacy/clinical effectiveness of inactivated influenza virus vaccines in adults. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of influenza. Oxford, England: Blackwell Science, 1998:358-72.
- Becher H, 2000, J Epidemiol Biostat, 5, 277
- 1999, MMWR Morb Mortal Wkly Rep, 48, 374
- 2000, MMWR Morb Mortal Wkly Rep, 49, 375
- 1997, MMWR Morb Mortal Wkly Rep, 46, 1
- Healthy People 2010: conference edition. Vol. 1. Washington, D.C.: Department of Health and Human Services, January 2000.
Cited by
Items 701–742 of 742
Marinho, A. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2019.tde-04062019-121515
Seasonal influenza vaccine effectiveness in asthma
Vasileiou, E. (2019) · ERA
El‐Bardissy, A., Adawi, R. M. A., Shible, A. A., Albu‐Mahmood, Z., Elgaily, D. E., & Abdelaziz, H. (2019) · Journal of Pharmaceutical Health Services Research · doi:10.1111/jphs.12321
“More than 90% of all pneumococcal infections can be prevented by a single pneumococcal vaccine, which protects against 23 different types of streptococcus pneumonia.([5,6]) Approximately 50% of these deaths could be avoided through the use of the pneumococcal vaccine.”
BackgroundShould we be vaccinating our patients against influenza?
Grattan, B. J. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2019.12.057
Crossley, K., & Peterson, P. K. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00315-5
Sinopalnikov, A. I., Chikina, S. Y., & Чучалин, А. Г. (2008) · PULMONOLOGIYA · doi:10.18093/0869-0189-2008-0-5-15-50 · Cited by 1
Contributions to the evidence base for reducing the impact of influenza in primary care
Verhees, R. A. F. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20211126rv
André†, F. E. (2021) · doi:10.33442/vt202125
Enhancing T-cell responses to vaccination of HIV-1 infected subjects on antiretroviral therapy
Ramirez, L. (2014) · ScholarlyCommons (University of Pennsylvania)
Cortes, J. M. S., Muñoz-Torrero, J. F. S., Sánchez, T. S., & Campoamor, A. C. (2005) · Revista Clínica Española · doi:10.1157/13076160
Anti-Aging Medicine LiteratureWatch
(2003) · Rejuvenation Research · doi:10.1089/109454503769684838
Kalp Yetmezliği Olan Hastalarda Farmasötik Bakım
Taner, N. (2021) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.827
Gohlke, H., Albus, C., Bönner, G., Darius, H., Eckert, S., Gohlke-Bärwolf, C., Gysan, D. B., Hahmann, H., Halle, N., Hambrecht, R., et al. (2012) · Der Kardiologe · doi:10.1007/s12181-011-0383-6 · Cited by 3
Linden, B. (2013) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2013.8.10.472
Rust, G., & Westney, G. E. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1160-8.10018-1
(2005) · Australian Journal on Ageing · doi:10.1111/j.1741-6612.2005.00073.x
Malone, M. L., & Danto-Nocton, E. S. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-2261-9.50014-8
Biedenbender, R., & Gravenstein, S. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-534-7_27
Sarubbi, F. A. (2003) · Southern Medical Journal · doi:10.1097/00007611-200308000-00002
Harle, I. A., & Dudgeon, D. J. (2012) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199694143.003.0046
Clinical effect of compound lidocaine cream on oropharyngeal flora under general anesthesia
Song, X., Zhou, L., Tang, L., Zhuang, M., Mao, X., & Peng, J. (2022) · Materials Express · doi:10.1166/mex.2022.2249
Mikrozirkulation und Atherosklerose
Haverich, A., & Boyle, E. C. (2023) · Springer eBooks · doi:10.1007/978-3-031-31766-8_7
GÖÇMEN, H., BÖLÜK, G., & Arslan, G. (2023) · Turkiye Klinikleri Archives of Lung · doi:10.5336/archlung.2023-98998
Evik, G., Kızılyıldırım, S., Akan, N., ERSÖZ, G., Külcü, D. P., Öz, F. B., Bulun, M. A., Kaynak, B. A., Salman, F., Horasan, E. Ş., et al. (2022) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.1229
Sacilotto, L. B., & GUERRAZZI, V. M. (2024) · doi:10.37085/jmm.2024.pre-comasp/
Effect of Oseltamivir Use on Follow-Up Stroke Mortality
Chuang, P.-H., Tzang, B., Tzang, C.-C., Kuo, I., Lin, C., & Hsu, T. (2025) · Pharmaceuticals · doi:10.3390/ph18060796
Malik, A., Ahmad, A., Aiman, S., Farrukh, S., Fatima, S., & Khan, A. A. (2025) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.70018
Inmunización y enfermedad cardiovascular en América Latina. El estudio CorVacc: fundamento y diseño
Wyss, F. S., López-Santi, R., Piskorz, D. L., Gupta, S., Múnera, A. G., Santi, P. L., Piskorz, G., Ulluauri, V., Gomez, J. E., Sueldo, M. D., et al. (2025) · Archivos de cardiología de México · doi:10.24875/acm.24000239
Immunization and Cardiovascular Disease in Latin America. The CorVacc Study: Results
Wyss, F., López-Santi, R., Piskorz, D. L., Márquez-González, H., Yáñez‐Gutiérrez, L., Gupta, S., Múnera, A. G., Santi, P. L., Piskorz, G., Ullauri-Solórzano, V. E., et al. (2025) · Global Heart · doi:10.5334/gh.1496
Fattore, G., Pongiglione, B., & Vezzosi, L. (2024) · Figshare · doi:10.6084/m9.figshare.25255778
Role of Influenza Vaccination in Cardiovascular Disease: Indian Expert Consensus
NAIR, T. K. H., Iyengar, S. S., Sawhney, J. P. S., & Ray, S. (2026) · Indian Journal of Clinical Cardiology · doi:10.1177/26324636251408616
Evaluation of cerebrovascular reactivity using transcranial Doppler in patients with influenza
Beslic, A. O., Čaljkušić, K., Matana, A., Ercegović, K. T., & Ivelja, M. P. (2026) · PLoS ONE · doi:10.1371/journal.pone.0340768
Wang, Y., Dai, J., Xie, Y., Yuan, S., & You, L. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2616903
“17 18–20 It consists of five components: Confidence, Collective Responsibility, Complacency, Constraints, and Calculation.”
Hong, C.-W., Chung, C., Hsu, Y., Lin, C., Chien, W., & Tsai, S. (2026) · Journal of Cardiology · doi:10.1016/j.jjcc.2026.03.002
Khan, A., Khan, M., Hammadeh, B. M., Ishaq, M. U., Naveed, H., Allana, S. S., Fudim, M., Mentz, R. J., Fonarow, G. C., & Biering‐Sørensen, T. (2026) · Heart Failure Reviews · doi:10.1007/s10741-026-10605-7
Appropriateness of antiviral prescribing for influenza in ambulatory care: A retrospective analysis
Arain, S. I., Abdulsalim, S., Khalawi, F., AlHamad, H. S., Thorakkattil, S. A., Anaam, M. S., AlSuwaidan, H. N., Dhamen, M. A. A., & Al‐Homoud, A. H. (2026) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2026.102353
Liu, P., 闵炎芳, Cai, C., Ren, Y., Hu, Z., Shen, Y., Niu, C., Liu, X., Wang, J., Chen, S., et al. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2683763
Najafi, K., Hosseini, K., & Biering-Sørensen, T. (2026) · Journal of Gerontology and Geriatrics · doi:10.3390/jgg74040043
Toward Preparedness: Opportunities and Obstacles
Knobler, S., Mack, A., Mahmoud, A. A. F., & Lemon, S. M. (2005)
Humane und aviaere Influenza – „Vogelgrippe“
Ruf, R. R., Werner, O., Schmitt, H. J., & Wutzler, P. (2005) · OpenAgrar · Cited by 1
Metadata
- Authors
- Nichol, K. L., Nordin, J., Mullooly, J., Lask, R., Fillbrandt, K., & Iwane, M.
- Affiliations
- University of Minnesota (US)
- HealthPartners (US)
- Kaiser Permanente (US)
- Centers for Disease Control and Prevention (US)
- ORCID
- Nordin, James
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-04-03
- Volume
- 348
- Issue
- 14
- Pages
- 1322-1332
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2116971894
- Cited by
- 752
- References
- 42
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 10 · 2023: 15 · 2022: 14 · 2021: 17 · 2020: 23 · 2019: 26 · 2018: 29 · 2017: 25 · 2016: 19 · 2015: 33 · 2014: 29 · 2013: 42 · 2012: 50
- FWCI
- 45.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Keywords
- influenza vaccination, influenza, stroke, heart disease, hospitalization, older adults, pneumonia, mortality, ischemic heart disease, cerebrovascular disease, upper respiratory tract infection, managed care, community-dwelling older adults, vaccine effectiveness, dementia, comorbidities, subgroup analysis
- MeSH terms
- Aged, Aged, 80 and over, Female, Heart Diseases, Hospitalization, Humans, Influenza, Human, Influenza Vaccines, Male, Mortality, Pneumonia, Risk, Logistic Models, Odds Ratio, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.